{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:00:06Z","timestamp":1791932406329,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.tube.2006.01.017","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T20:16:15Z","timestamp":1141244175000},"page":"211-217","source":"Crossref","is-referenced-by-count":54,"title":["Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization"],"prefix":"10.1016","volume":"86","author":[{"given":"Zhou","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Lichty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2006.01.017_bib1","unstructured":"World Health Organization. WHO vaccine preventable diseases\u2014global summary. 2001."},{"issue":"Suppl 3","key":"10.1016\/j.tube.2006.01.017_bib2","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette\u2013Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2006.01.017_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2004.10.002","article-title":"TB vaccines for the world","volume":"85","author":"Hewinson","year":"2005","journal-title":"Tuberculosis (Edinburg)"},{"key":"10.1016\/j.tube.2006.01.017_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1586\/14760584.1.3.341","article-title":"Tuberculosis vaccines: the past, present and future","volume":"1","author":"Wang","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tube.2006.01.017_bib5","series-title":"Focus on tuberculosis research","first-page":"141","article-title":"The prospects of mucosal vaccination against pulmonary tuberculosis","author":"Santosuosso","year":"2005"},{"key":"10.1016\/j.tube.2006.01.017_bib6","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/14712598.4.9.1493","article-title":"Tuberculosis vaccine development: research, regulatory and clinical strategies","volume":"4","author":"Brennan","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.tube.2006.01.017_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/vim.2005.18.283","article-title":"Adenoviral vectors for mucosal vaccination against infectious diseases","volume":"18","author":"Santosuosso","year":"2005","journal-title":"Viral Immunol"},{"key":"10.1016\/j.tube.2006.01.017_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomized controlled trial of single BCG, repeated BCG or combined BCG and killed Mycobacterium leprae vaccine for leprosy and tuberculosis in Malawi","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2006.01.017_bib9","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/IAI.71.11.6411-6419.2003","article-title":"Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination","volume":"71","author":"Buddle","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.01.017_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1471-4906(01)01865-8","article-title":"TB vaccines: progress and problems","volume":"22","author":"Andersen","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.tube.2006.01.017_bib11","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/IAI.70.6.3111-3121.2002","article-title":"Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis","volume":"70","author":"Doherty","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.01.017_bib12","first-page":"188","article-title":"DNA vaccines\u2014challenges in delivery","volume":"2","author":"Pachuk","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.tube.2006.01.017_bib13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.vaccine.2004.09.008","article-title":"Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis","volume":"23","author":"Cardona","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2006.01.017_bib14","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette\u2013Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.01.017_bib15","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.01.017_bib16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2006.01.017_bib17","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/IAI.73.6.3814-3816.2005","article-title":"Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in Guinea pigs","volume":"73","author":"Williams","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2006.01.017_bib18","series-title":"Vaccines","first-page":"492","article-title":"Adenovirus vaccines","author":"Rubin","year":"1998"},{"key":"10.1016\/j.tube.2006.01.017_bib19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0958-1669(95)80097-2","article-title":"The use of adenoviral vectors for gene therapy and gene transfer in vivo","volume":"6","author":"Bramson","year":"1995","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.tube.2006.01.017_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.gt.3302071","article-title":"Gene therapy progress and prospects: adenoviral vectors","volume":"10","author":"St George","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.tube.2006.01.017_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jlb.59.4.481","article-title":"Gene Transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammation","volume":"59","author":"Xing","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.tube.2006.01.017_bib22","first-page":"161","article-title":"Transient transgenic approaches for investigating the role of granulocyte-macrophage colony-stimulating factor in pulmonary inflammatory and immune diseases","volume":"4","author":"Xing","year":"2000","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.tube.2006.01.017_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenovirus as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.tube.2006.01.017_bib24","unstructured":"Emini E. Ongoing development and evaluation of a potential HIV-1 vaccine using a replication-defective adenoviral vector. In: KeyStone conference on HIV vaccines, Banff, March 29\u2013April 4, 2003 [Abstract 012]."},{"key":"10.1016\/j.tube.2006.01.017_bib25","unstructured":"Perperi L. HVTN vaccines in development: nonreplicating adenoviral vector vaccines. http:\/\/chi.ucsf.edu\/vaccines, 2005."},{"key":"10.1016\/j.tube.2006.01.017_bib26","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI118503","article-title":"Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions","volume":"97","author":"Xing","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tube.2006.01.017_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI119590","article-title":"Adenovector-mediated gene transfer of active transforming growth factor \u00df-1 induces prolonged severe fibrosis in rat lung","volume":"100","author":"Sime","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tube.2006.01.017_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2249.1998.00652.x","article-title":"Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation","volume":"113","author":"Lei","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2006.01.017_bib29","first-page":"615","article-title":"Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans\u2019 cell\/macrophage accumulation and dermal fibrosis","volume":"77","author":"Xing","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.tube.2006.01.017_bib30","doi-asserted-by":"crossref","first-page":"13407","DOI":"10.1128\/JVI.77.24.13407-13411.2003","article-title":"Detailed analysis of the CD8 T cell response following adenovirus vaccination","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2006.01.017_bib31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.gt.3300371","article-title":"Adenoviral vector-mediated IL-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia","volume":"4","author":"Xing","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.tube.2006.01.017_bib32","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.4049\/jimmunol.174.12.7986","article-title":"Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen","volume":"174","author":"Santosuosso","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2006.01.017_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","article-title":"Vesicular stomatitis virus: re-inventing the bullet","volume":"10","author":"Lichty","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.tube.2006.01.017_bib34","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1128\/JVI.75.13.6107-6114.2001","article-title":"Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development","volume":"75","author":"Flanagan","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2006.01.017_bib35","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2006.01.017_bib36","series-title":"Fields virology","first-page":"1121","article-title":"Rhabdoviridae: the viruses and their replication","author":"Wagner","year":"1996"},{"key":"10.1016\/j.tube.2006.01.017_bib37","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S1097-2765(00)00120-9","article-title":"Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98","volume":"6","author":"von Kobbe","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.tube.2006.01.017_bib38","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1128\/MCB.20.22.8590-8601.2000","article-title":"The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes","volume":"20","author":"Petersen","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.tube.2006.01.017_bib39","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1073\/pnas.151240998","article-title":"Multiple vesiculoviral matrix proteins inhibit both nuclear export and import","volume":"98","author":"Petersen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2006.01.017_bib40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tube.2006.01.017_bib41","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.tube.2006.01.017_bib42","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":"Roberts","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2006.01.017_bib43","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.74.10.4652-4657.2000","article-title":"Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies","volume":"74","author":"Schlereth","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.tube.2006.01.017_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.tube.2006.01.017_bib45","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2006.01.017_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.tube.2006.01.017_bib47","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/IAI.74.2.1416-1418.2006","article-title":"Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing mycobacterial antigen 85A and BCG","volume":"74","author":"Vordermeier","year":"2006","journal-title":"Infect Immun"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297920600031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297920600031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:12:38Z","timestamp":1586736758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297920600031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":47,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S147297920600031X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2006.01.017","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}